BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15067040)

  • 1. Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection.
    Artis D; Johnson LM; Joyce K; Saris C; Villarino A; Hunter CA; Scott P
    J Immunol; 2004 Apr; 172(8):4672-5. PubMed ID: 15067040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection.
    Anderson CF; Stumhofer JS; Hunter CA; Sacks D
    J Immunol; 2009 Oct; 183(7):4619-27. PubMed ID: 19748991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection.
    Yoshida H; Hamano S; Senaldi G; Covey T; Faggioni R; Mu S; Xia M; Wakeham AC; Nishina H; Potter J; Saris CJ; Mak TW
    Immunity; 2001 Oct; 15(4):569-78. PubMed ID: 11672539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment.
    Takeda A; Hamano S; Yamanaka A; Hanada T; Ishibashi T; Mak TW; Yoshimura A; Yoshida H
    J Immunol; 2003 May; 170(10):4886-90. PubMed ID: 12734330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major.
    Artis D; Speirs K; Joyce K; Goldschmidt M; Caamaño J; Hunter CA; Scott P
    J Immunol; 2003 Feb; 170(4):1995-2003. PubMed ID: 12574369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.
    Jones DE; Buxbaum LU; Scott P
    J Immunol; 2000 Jul; 165(1):364-72. PubMed ID: 10861073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection.
    Monteforte GM; Takeda K; Rodriguez-Sosa M; Akira S; David JR; Satoskar AR
    J Immunol; 2000 Jun; 164(11):5890-3. PubMed ID: 10820270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
    Reiner SL; Zheng S; Wang ZE; Stowring L; Locksley RM
    J Exp Med; 1994 Feb; 179(2):447-56. PubMed ID: 7905017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice.
    Padigel UM; Kim N; Choi Y; Farrell JP
    J Immunol; 2003 Nov; 171(10):5437-41. PubMed ID: 14607948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis.
    Yamanaka A; Hamano S; Miyazaki Y; Ishii K; Takeda A; Mak TW; Himeno K; Yoshimura A; Yoshida H
    J Immunol; 2004 Mar; 172(6):3590-6. PubMed ID: 15004160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
    Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
    J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid IL-4 production by Leishmania homolog of mammalian RACK1-reactive CD4(+) T cells in resistant mice treated once with anti-IL-12 or -IFN-gamma antibodies at the onset of infection with Leishmania major instructs Th2 cell development, resulting in nonhealing lesions.
    Launois P; Gumy A; Himmelrich H; Locksley RM; Röcken M; Louis JA
    J Immunol; 2002 May; 168(9):4628-35. PubMed ID: 11971011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
    Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
    J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major.
    Johnson LM; Scott P
    J Immunol; 2007 Jun; 178(11):7259-66. PubMed ID: 17513775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
    Mocci S; Coffman RL
    J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation.
    Padigel UM; Perrin PJ; Farrell JP
    J Immunol; 2001 Nov; 167(10):5874-9. PubMed ID: 11698463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice.
    Miyazaki Y; Inoue H; Matsumura M; Matsumoto K; Nakano T; Tsuda M; Hamano S; Yoshimura A; Yoshida H
    J Immunol; 2005 Aug; 175(4):2401-7. PubMed ID: 16081811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.